Page 56 - Product Testing News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. National Evaluation System for health Technology Coordinating Center Welcomes Regenstrief Institute to NESTcc Research Network January 14, 2021 GMT ARLINGTON, Va.--(BUSINESS WIRE)--Jan 14, 2021-- The National Evaluation System for health Technology Coordinating Center ( NESTcc ), an initiative of the Medical Device Innovation Consortium ( MDIC ), today announced the Regenstrief Institute as the newest ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update Biomerica, Inc.January 15, 2021 GMT Biomerica expects completion of enrollment of its Irritable Bowel Syndrome Diagnostic-Guided Therapy clinical trial by end of April, 2021   FDA actively reviewing Company’s EUA submission for its first of its kind “at-home” Blood Collection kit used with the Biomeric...

Press release content from Wired Release. The AP news staff was not involved in its creation. Cervical Cancer Diagnostic Tests Market Revenue Statistics and Top Companies With Assessment Period by 2031 January 14, 2021 GMT Pune, Maharashtra, India, January 14 2021 (Wiredrelease) Prudour Pvt. Ltd :The research study on global Cervical Cancer Diagnostic Tests market presents an extensive analysis of current Cervical Cancer Diagnostic Tests trends, market size, drivers, Cervical Cancer Diagnostic ...

Press release content from Business Wire. The AP news staff was not involved in its creation.

Press release content from Business Wire. The AP news staff was not involved in its creation. NantKwest, ImmunityBio Announce Positive Interim Data on Survival Rates in Metastatic Pancreatic Cancer Trials January 13, 2021 GMT EL SEGUNDO & CULVER CITY, Calif.--(BUSINESS WIRE)--Jan 13, 2021-- NantKwest, Inc. ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, and ImmunityBio, Inc., a privately-held immunotherapy company, today announced early interim results of its P...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie Genmab A/SJanuary 13, 2021 GMT Company Announcement Milestone triggered by progress in Phase 3 study of epcoritamab in diffuse large B-cell lymphoma Copenhagen, Denmark; January 13, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that it has reached the first milestone in its collaboration with AbbVie. A USD 40 million milestone ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Call for Entries: National Pediatric Cancer Foundation and Ravensburger Partner for Crowdsourced “Puzzles Fund the Cure” Design Contest January 14, 2021 GMT The National Pediatric Cancer Foundation (NPCF) has teamed up with Ravensburger, the world leader in jigsaw puzzles, to help piece together a cure for childhood cancer with the launch of the “ Puzzles Fund the Cure Design Contest.” Now t...

Press release content from Business Wire. The AP news staff was not involved in its creation. U.S. IDE Trial Results for Glaukos’ iStent infinite™ Show Substantial Reduction in IOP January 13, 2021 GMT SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Jan 13, 2021-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that 12-month U.S. Investigatio...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 ... Mateon Therapeutics, Inc.January 13, 2021 GMT AGOURA HILLS, California, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-β therapeutics for oncology and COVID-19, reported positive interim results from its ARTI-19 clinical trial evaluating A...

Press release content from Business Wire. The AP news staff was not involved in its creation. PureTech Founded Entity Follica Adds Two Leaders in Aesthetic Medicine and Dermatology to its Board of Directors January 14, 2021 GMT BOSTON--(BUSINESS WIRE)--Jan 14, 2021-- PureTech Health plc (LSE: PRTC, NASDAQ: PRTC) (“PureTech” or the “Company”) is pleased to note that its Founded Entity, Follica, today announced the appointment of two veteran biotech executives to its Board of Directors. A...